Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib
Author:
Publisher
Elsevier BV
Subject
Urology
Reference30 articles.
1. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma;Motzer;J Clin Oncol,2002
2. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009
3. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?;Culp;Cancer,2010
4. New treatments for renal cell carcinoma: targeted therapies;Saylor;J Natl Compr Canc Netw,2009
5. Clinical Trial to Assess the Importance of Nephrectomy (CARMENA). ClinicalTrials.gov Web site. http://www.clinicaltrials.gov/ct2/show/NCT00930033.
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC;Nature Reviews Urology;2023-07-03
2. 2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS);The Korean Journal of Urological Oncology;2022-08-31
3. Tumor diameter response in patients with metastatic clear cell renal cell carcinoma is associated with overall survival;Urologic Oncology: Seminars and Original Investigations;2021-12
4. Prospective pharmacological methodology for establishing and evaluating anti-cancer drug resistant cell lines;BMC Cancer;2021-09-25
5. Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database;Technology in Cancer Research & Treatment;2021-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3